Evidence summary: What are the dermatological manifestations of COVID-19 and what are the implications for assessment and treatment? [v1.0]
dc.contributor.author | National Health Library & Knowledge Service (NHLKS) | |
dc.contributor.author | Hegarty, Ronan | |
dc.contributor.author | Clark, Helen | |
dc.contributor.author | Leen, Brendan | |
dc.date.accessioned | 2020-07-02T10:09:54Z | |
dc.date.available | 2020-07-02T10:09:54Z | |
dc.date.issued | 2020-07-01 | |
dc.identifier.uri | http://hdl.handle.net/10147/627860 | |
dc.description | Dermatological manifestations in patients with COVID-19 are not well comprehended. There have been reports of maculopapular2, 3, urticarial1, 2, 16, 20., 30 and vesicular eruptions1, 2, 16, and transient livedo reticularis1, 2, 16. 24, 34. Reddish-purple nodules on the distal digits similar in appearance to pernio or chiblains have also been described1, 2, 4, 11, 16, 26, mainly in children and young adults with documented or suspected COVID -19 although an association has not yet been clearly established2. The published data currently available to suggest a potential link between dermatologic manifestations and COVID-19 are small in size; other reports have been mainly anecdotal7. It is uncertain whether skin lesions on COVID-19 patients are from viral infection, systemic consequences of the infection or drugs the patient may be prescribed as a result of the infection. It is important to ascertain definitively whether cutaneous manifestations are caused by COVID-19 or as a result of drugs used to treat the infection or even as a consequence of worsening of previous dermatological injuries6. Clinical images of cutaneous manifestations are difficult to obtain because introducing a photographic device into a restricted room could pose an infection risk. A simple and easily reproducible method involving zip-lock transparent bags made of low-density polyethylene has been put forward as a possible solution. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Health Service Executive | en_US |
dc.relation.ispartofseries | Evidence summaries | en_US |
dc.subject | CORONAVIRUS | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | SKIN DISORDER | en_US |
dc.subject | DERMATOLOGY | en_US |
dc.title | Evidence summary: What are the dermatological manifestations of COVID-19 and what are the implications for assessment and treatment? [v1.0] | en_US |
dc.type | Other | en_US |
refterms.dateFOA | 2020-07-02T10:09:56Z |
Files in this item
This item appears in the following Collection(s)
-
HSE Library Summaries of Evidence
Evidence summaries and reviews on the management and treatment of Novel Coronavirus Covid-19 and other clinical topics